flu shots are a small part of the picture. revenues are returning to their perennial upward trend. margins continue to expand. costs have been cut substantially. expansion to europe added in beginning this quarter. look for a very good earnings report this quarter and a positive outlook. walgreen stock is outperforming the competition over the past 6 months, and imo will do the same for at least the next several quarters.